Epstein Secrets

a rating committee decision with respect to a proposed acquisition. In March 2016, Standard and Poor's, a credit rating agency in New York, assigned Pinto-Thomazto work on a RES for the Sherwin-Williams Company in advance of its contemplated but unannounced acquisition of the Valspar Corporation, according to

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

a rating committee decision with respect to a proposed acquisition. In March 2016, Standard and Poor's, a credit rating agency in New York, assigned Pinto-Thomazto work on a RES for the Sherwin-Williams Company in advance of its contemplated but unannounced acquisition of the Valspar Corporation, according to

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

a rating committee decision with respect to a proposed acquisition. In March 2016, Standard and Poor's, a credit rating agency in New York, assigned Pinto-Thomazto work on a RES for the Sherwin-Williams Company in advance of its contemplated but unannounced acquisition of the Valspar Corporation, according to

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. EFTA00085695 The office also said Collins may have broken House ethics rules by persuad

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

a rating committee decision with respect to a proposed acquisition. In March 2016, Standard and Poor's, a credit rating agency in New York, assigned Pinto-Thomazto work on a RES for the Sherwin-Williams Company in advance of its contemplated but unannounced acquisition of the Valspar Corporation, according to

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

a rating committee decision with respect to a proposed acquisition. In March 2016, Standard and Poor's, a credit rating agency in New York, assigned Pinto-Thomazto work on a RES for the Sherwin-Williams Company in advance of its contemplated but unannounced acquisition of the Valspar Corporation, according to